Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("DEL PRATO, Stefano")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 100

  • Page / 4
Export

Selection :

  • and

The place of sulfonylureas in the therapy for type 2 diabetes mellitusDEL PRATO, Stefano; PULIZZI, Nicolo.Metabolism, clinical and experimental. 2006, Vol 55, Num 5, issn 0026-0495, S20-S27, SUP1Conference Paper

Sulfonylureas in the therapy of type 2 diabetes: where do we stand today?: Proceedings of a symposium held on the occasion of the 41st Annual Meeting of the European Association for the Study of Diabetes, September 11, 2005DEL PRATO, Stefano.Metabolism, clinical and experimental. 2006, Vol 55, Num 5, issn 0026-0495, 29 p., SUP1Conference Proceedings

Proceedings of the 4th World Congress on Controversies to Consensus in Diabetes Obesity and Hypertension (CODHy)RAZ, Itamar; DEL PRATO, Stefano.Diabetes care. 2013, Vol 36, issn 0149-5992, 233 p., SUP2Conference Proceedings

Proceedings of the 3rd World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy)RAZ, Itamar; DEL PRATO, Stefano.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, 287 p.Serial Issue

Effects of gliclazide beyond metabolic controlCERIELLO, Antonio.Metabolism, clinical and experimental. 2006, Vol 55, Num 5, issn 0026-0495, S10-S15, SUP1Conference Paper

The importance of first-phase insulin secretion : implications for the therapy of type 2 diabetes mellitusDEL PRATO, Stefano; TIENGO, Antonio.Diabetes/metabolism research and reviews (Print). 2001, Vol 17, Num 3, pp 164-174, issn 1520-7552Article

Insulin as an Early Treatment for Type 2 Diabetes: ORIGIN or end of an old question?DEL PRATO, Stefano; DARDANO, Angela; BIANCHI, Cristina et al.Diabetes care. 2013, Vol 36, issn 0149-5992, S198-S204, SUP2Conference Paper

Activation of GPR40 as a Therapeutic Target for the Treatment of Type 2 DiabetesBURANT, Charles F.Diabetes care. 2013, Vol 36, issn 0149-5992, S175-S179, SUP2Conference Paper

Heart in Diabetes: A Microvascular DiseaseLAAKSO, Markku.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, S145-S149Article

Comparative Efficiency and Safety of Pharmacological Approaches to the Management of ObesityHAINER, Vojtech.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, S349-S354Article

Guideline Approach to Therapy in Patients With Newly Diagnosed Type 2 DiabetesRAZ, Itamar.Diabetes care. 2013, Vol 36, issn 0149-5992, S139-S144, SUP2Conference Paper

The Case for: Hypoglycemia Is of Cardiovascular ImportanceLALIC, Nebojsa M.Diabetes care. 2013, Vol 36, issn 0149-5992, S264-S266, SUP2Conference Paper

Insulin: Potential Negative Consequences of Early Routine Use in Patients With Type 2 DiabetesLEBOVITZ, Harold E.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, S225-S230Article

Incretin Effects on β-Cell Function, Replication, and Mass: The human perspectiveGARBER, Alan J.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, S258-S263Article

Myocardial, Perivascular, and Epicardial FatIOZZO, Patricia.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, S371-S379Article

Diabetes and Cardiovascular Disease: When it comes to lipids, statins are all you needBITZUR, Rafael.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, S380-S382Article

Changing the Treatment Paradigm for Type 2 DiabetesDEL PRATO, Stefano; PENNO, Giuseppe; MICCOLI, Roberto et al.Diabetes care. 2009, Vol 32, Num 3, pp 5217-5222, issn 0149-5992, 6 p., SUPConference Paper

Combining Incretin-Based Therapies With Insulin: Realizing the potential in type 2 diabetesVORA, Jiten.Diabetes care. 2013, Vol 36, issn 0149-5992, S226-S232, SUP2Conference Paper

Insulin Therapy and CancerHOME, Philip.Diabetes care. 2013, Vol 36, issn 0149-5992, S240-S244, SUP2Conference Paper

Role of Bile Acid Sequestrants in the Treatment of Type 2 DiabetesHANDELSMAN, Yehuda.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, S244-S250Article

Limitations and Future Treatment Options in Type 2 Diabetes With Renal ImpairmentRITZ, Eberhard.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, S330-S334Article

β-cell function and anti-diabetic pharmacotherapyDEL PRATO, Stefano; BIANCHI, Cristina; MARCHETTI, Piero et al.Diabetes/metabolism research and reviews (Print). 2007, Vol 23, Num 7, pp 518-527, issn 1520-7552, 10 p.Article

Overcoming the hurdles to achieving glycemic controlSHAW, Kenneth M.Metabolism, clinical and experimental. 2006, Vol 55, Num 5, issn 0026-0495, 6S-S9, SUP1Conference Paper

Cardiovascular Importance of Hyperglycemia and HypoglycemiaTKAC, Ivan.Diabetes care. 2013, Vol 36, issn 0149-5992, S267-S271, SUP2Conference Paper

DPP-4 Inhibitors: Impact on glycemic control and cardiovascular risk factorsDICKER, Dror.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, S276-S278Article

  • Page / 4